Biotechnology UBS Bullish On This Depression Drug Maker, Says Alzheimer’s Agitation Data Is Attractive Catalyst – Axsome Therapeutics (NASDAQ:AXSM) Read more
Stockmarkets UBS flags up to $1 billion in share buybacks with Credit Suisse takeover on track Reuters via biedexmarkets.com Read more